The Small Space Marketplace

List Your Space

Find Space

Home About Us Executive Subscriber Membership RENTV Conferences Newsletter Contact Us Advertise
September 29, 2022
 Search RENTV
   Go!
 The REview
 News
News Home Page
Southern California
Northern California
Pacific Northwest
Texas/Southwest
Retail
Multifamily
Financing
Prop. Management
Archives
Press Releases
 R. E. Marketplace
Service Providers
JobWorks
Property Spotlight
 RENTV  Conferences
Subscriber Login:
  
Email      
    Go!
Password      
Forgot Password?



ETC... ETC...
Printer-friendly Version   Email an Associate
Sonoma Biotherapeutics Inks Lease Yet-to-be-Developed R&D Facility in Seattle

8/26/22

Sonoma Biotherapeutics Inc has agreed to a long-term lease agreement for a yet-to-be-developed, 83k sf Research and Development (R&D) and Manufacturing Center in Seattle. The center will be located at 501 Elliott Avenue West, a property owned by Office Properties Income Trust and being redeveloped by The RMR Group into Unison Elliott Bay. Sonoma Bio will serve as the anchor tenant kicking off leasing activity at the three-building project.

Sonoma Bio is a clinical-stage biotechnology company focused on developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases. The state-of-the-art facility will support the R&D and manufacturing of Sonoma Bioís pipeline of gene-modified Treg therapies for autoimmune and inflammatory diseases at scale.

Sonoma Bioís new R&D and Manufacturing Center will include the development and use of cutting-edge technologies and capabilities, from cell selection and genetic modification to intelligent manufacturing automation and information technology systems. The integration of this infrastructure and scientific expertise will enable Sonoma Bio to move efficiently from molecular target identification to in-house full-scale production for multiple products and indications in Phase 2 clinical trials and beyond.

Steve Lico of Cushman & Wakefield and Kris Richey Curtis of JLL represented Sonoma Bio in the transaction. Lico and Richey Curtis have partnered to represent Sonoma Bio since the biotech companyís inception in 2019. Tim Jones and Joe Gowan of JLL serve as the projectís leasing team and represented RMR in the lease.




Return to the previous page


 


 


 
 
 



Home | About Us | Newsletter | Contact Us | Executive Subscriber Membership | Executive Subscriber Home | Advertise
Southern California | Northern California | Pacific Northwest | Southwest | Retail | Multifamily | Financing | Property Management
Archives | Press Releases | Service Providers | JobWorks | Property Listings

Copyright © 2022 by RENTV, All Rights Reserved
Website designed by Regency Web Services, Inc. and powered by Lightning Media